RB1 and hypoparathyroidism-retardation-dysmorphism syndrome: HRP tumors demonstrated significantly increased RB1 mRNA expression levels, with a median of 983 normalized transcripts per million (nTPM) compared to 884 nTPM in HRD tumors (p < 0.0001).